Novel Immunotherapy Approaches Targeting TIGIT: Updates and Perspectives for the Oncology Care Team

Gain insight into the emerging role of TIGIT as a target for immunotherapy and learn about therapies in development through expert commentaries podcasts a text-based module and a downloadable slideset.

Share

Program Content

Activities

Targeting TIGIT
Targeting TIGIT: Understanding New Approaches for Inhibiting the Immune Checkpoint Pathway
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 07, 2022

Expires: April 06, 2023

Anti-TIGIT Therapy
Anti-TIGIT Therapy: Overview of Current Clinical Evidence and Key Ongoing Trials
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2022

Expires: April 14, 2023

Activities

Novel Immunotherapy Approaches Targeting TIGIT
Novel Immunotherapy Approaches Targeting TIGIT: Updates and Perspectives for the Oncology Care Team
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2022

Expires: April 26, 2023

Slideset: Novel Immunotherapy Approaches Targeting TIGIT
Slideset: Novel Immunotherapy Approaches Targeting TIGIT: Updates and Perspectives for the Oncology Care Team
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2022

Expires: April 26, 2023

Activities

Targeting TIGIT: Commentary
Targeting TIGIT: A Novel Mechanism to Inhibit the Immune Checkpoint Pathway
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2022

Expires: April 13, 2023

Anti-TIGIT Therapy
Anti-TIGIT Therapy: Current Evidence and Key Ongoing Trials
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2022

Expires: May 02, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group